Breaking the Ice: Breakthrough CRISPR-Based RNA Technology Turns "Cold" Prostate Tumors Visible to Immunotherapy
Executive Overview Prostate cancer has long stood as one of modern oncology’s most stubborn fortresses against immunotherapy. While revolutionary immune-based treatments have rewritten survival odds for patients dealing with melanoma,…